FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Hanson

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Lyme Disease

Concepts & Ideas

Molecular Sequence Data

Genes & Molecular Sequences

Co-author Network

Publications

TOP 3
Mark S Hanson; Robert Edelman
Progress and controversy surrounding vaccines against Lyme disease.
David R Cassatt; Christine A Fazenbaker; Christine M Bachy; Mark S Hanson
Preclinical modeling of improved amifostine (Ethyol) use in radiation therapy.
Nancy D Ulbrandt; David R Cassatt; Nita K Patel; William C Roberts; Christine M Bachy; Christine A Fazenbaker; Mark S Hanson
Conformational nature of the Borrelia burgdorferi decorin binding protein A epitopes that elicit protective antibodies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Hanson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: Mark S Hanson; Robert Edelman
Progress and controversy surrounding vaccines against Lyme disease.
Expert review of vaccines 2003;2(5):683-703.
2002: David R Cassatt; Christine A Fazenbaker; Christine M Bachy; Mark S Hanson
Preclinical modeling of improved amifostine (Ethyol) use in radiation therapy.
Seminars in radiation oncology 2002;12(1 Suppl 1):97-102.
2001: Nancy D Ulbrandt; David R Cassatt; Nita K Patel; William C Roberts; Christine M Bachy; Christine A Fazenbaker; Mark S Hanson
Conformational nature of the Borrelia burgdorferi decorin binding protein A epitopes that elicit protective antibodies.
Infection and immunity 2001;69(8):4799-807.
2001: Theresa M Wizemann; Jon H Heinrichs; John E Adamou; Alice L Erwin; Charles Kunsch; Gil H Choi; Steven C Barash; C A Rosen; H R Masure; Elaine I Tuomanen; Antony Gayle; Yambasu Albert Brewah; William D Walsh; Philip R Barren; Raju Lathigra; Mark S Hanson; Solomon Langermann; Syd Johnson; Scott Koenig
Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection.
Infection and immunity 2001;69(3):1593-8.
2000: Mark S Hanson; Nita K Patel; David R Cassatt; Nancy D Ulbrandt
Evidence for vaccine synergy between Borrelia burgdorferi decorin binding protein A and outer surface protein A in the mouse model of lyme borreliosis.
Infection and immunity 2000;68(11):6457-60.
2000: Alice L Erwin; Yambasu Albert Brewah; Debra A Couchenour; Philip R Barren; Stephen J Burke; Gil H Choi; Raju Lathigra; Mark S Hanson; J N Weiser
Role of lipopolysaccharide phase variation in susceptibility of Haemophilus influenzae to bactericidal immunoglobulin M antibodies in rabbit sera.
Infection and immunity 2000;68(5):2804-7.
1999: Jon H Heinrichs; LaVette E Gatlin; Charles Kunsch; Gil H Choi; Mark S Hanson
Identification and characterization of SirA, an iron-regulated protein from Staphylococcus aureus.
Journal of bacteriology 1999;181(5):1436-43.
1999: Robert Edelman; K Palmer; Karin G Russ; H P Secrest; J A Becker; Sacared A Bodison; Judith G Perry; A R Sills; A G Barbour; C J Luke; Mark S Hanson; C Kendall Stover; Jeanne E Burlein; Geetha P Bansal; Edward M Connor; Scott Koenig
Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine.
Vaccine 1999;17(7-8):904-14.
1998: David R Cassatt; Nita K Patel; Nancy D Ulbrandt; Mark S Hanson
DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodies.
Infection and immunity 1998;66(11):5379-87.
1998: William C Roberts; Brian A Mullikin; Raju Lathigra; Mark S Hanson
Molecular analysis of sequence heterogeneity among genes encoding decorin binding proteins A and B of Borrelia burgdorferi sensu lato.
Infection and immunity 1998;66(11):5275-85.
1998: Mark S Hanson; David R Cassatt; BP Guo; Nita K Patel; Michael P McCarthy; D W Dorward; Magnus Höök
Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection.
Infection and immunity 1998;66(5):2143-53.
1997: Claire M Fraser-Liggett; S Casjens; W M Huang; G G Sutton; R Clayton; Raju Lathigra; Owen R White; K A Ketchum; R Dodson; E K Hickey; Michelle G Giglio; B Dougherty; J F Tomb; R D Fleischmann; D Richardson; J Peterson; A R Kerlavage; John Quackenbush; Steven L Salzberg; Mark S Hanson; R van Vugt; N Palmer; M D Adams; J Gocayne; J Weidman; T Utterback; L Watthey; L McDonald; P Artiach; C Bowman; S Garland; C Fuji; M D Cotton; K Horst; K Roberts; B Hatch; Hamilton O Smith; J C Venter
Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi.
Nature 1997;390(6660):580-6.
1995: Mark S Hanson; C V Lapcevich; Shirley L Haun
Progress on development of the live BCG recombinant vaccine vehicle for combined vaccine delivery.
Annals of the New York Academy of Sciences 1995;754():214-21.
1995: Mark S Hanson; Geetha P Bansal; Solomon Langermann; C Kendall Stover; I Orme
Efficacy and safety of live recombinant BCG vaccines.
Developments in biological standardization 1995;84():229-36.
1994: Solomon Langermann; Susan R Palaszynski; Jeanne E Burlein; Scott Koenig; Mark S Hanson; D E Briles; C Kendall Stover
Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.
The Journal of experimental medicine 1994;180(6):2277-86.
1994: C Kendall Stover; Geetha P Bansal; S Langerman; Mark S Hanson
Protective immunity elicited by rBCG vaccines.
Developments in biological standardization 1994;82():163-70.
1993: C Kendall Stover; Geetha P Bansal; Mark S Hanson; Jeanne E Burlein; Susan R Palaszynski; James F Young; Scott Koenig; D B Young; A Sadziene; A G Barbour
Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.
The Journal of experimental medicine 1993;178(1):197-209.
1992: Mark S Hanson; C Slaughter; E J Hansen
The hbpA gene of Haemophilus influenzae type b encodes a heme-binding lipoprotein conserved among heme-dependent Haemophilus species.
Infection and immunity 1992;60(6):2257-66.
1992: Mark S Hanson; S E Pelzel; Jo L Latimer; U Muller-Eberhard; E J Hansen
Identification of a genetic locus of Haemophilus influenzae type b necessary for the binding and utilization of heme bound to human hemopexin.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(5):1973-7.
1992: C Kendall Stover; Vidal de la Cruz; Geetha P Bansal; Mark S Hanson; Thomas R Fuerst; William R. Jacobs Jr.; B R Bloom
Use of recombinant BCG as a vaccine delivery vehicle.
Advances in experimental medicine and biology 1992;327():175-82.
1991: Leslie D Cope; R Yogev; J Mertsola; Jo L Latimer; Mark S Hanson; George H McCracken; E J Hansen
Molecular cloning of a gene involved in lipooligosaccharide biosynthesis and virulence expression by Haemophilus influenzae type B.
Molecular microbiology 1991;5(5):1113-24.
1991: Mark S Hanson; E J Hansen
Molecular cloning, partial purification, and characterization of a haemin-binding lipoprotein from Haemophilus influenzae type b.
Molecular microbiology 1991;5(2):267-78.
1989: J Mertsola; Octavio Ramilo; Xavier Sáez-Llorens; Mark S Hanson; George H McCracken; E J Hansen
Specific detection of Haemophilus influenzae type b lipooligosaccharide by a polymyxin B monoclonal antibody assay.
Journal of immunological methods 1989;122(2):219-26.
1989: Mark S Hanson; Leslie D Cope; E J Hansen
Expression of the heat-modifiable major outer membrane protein of Haemophilus influenzae type b is unrelated to virulence.
Infection and immunity 1989;57(6):1639-46.
1988: Mark S Hanson; J Hempel; C C Brinton
Purification of the Escherichia coli type 1 pilin and minor pilus proteins and partial characterization of the adhesin protein.
Journal of bacteriology 1988;170(8):3350-8.
1988: Mark S Hanson; C C Brinton
Identification and characterization of E. coli type-1 pilus tip adhesion protein.
Nature 1988;332(6161):265-8.